Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA1 | P00915 | 1/20 | 0.33 |
| ▸ | CA2 | P00918 | 1/20 | 0.33 |
| ▸ | CA9 | Q16790 | 1/20 | 0.33 |
| ▸ | CES2 | O00748 | 1/20 | 0.32 |
| ▸ | CES1 | P23141 | 1/20 | 0.32 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL516304 | 0.77 | CA1 (0.36) | CA1CA2CA9HSD17B10 | |
| SCHEMBL34317 | 0.77 | CA1 (0.36) | CA1CA2CA9HSD17B10 | |
| SCHEMBL27532940 | 0.75 | CES2 (0.32) | CES2CES1 | |
| SCHEMBL9800762 | 0.75 | — | — | |
| SCHEMBL16814869 | 0.74 | CA1 (0.35) | CA1CA2CA9HSD17B10 | |
| SCHEMBL570928 | 0.74 | PREP (0.39) | CA1CA2CA9HSD17B10 | |
| SCHEMBL18697361 | 0.74 | CA1 (0.35) | CA1CA2CA9CES2CES1 | |
| SCHEMBL176317 | 0.74 | CA1 (0.35) | CA1CA2CA9HSD17B10 | |
| SCHEMBL1256979 | 0.74 | CA1 (0.31) | CA1CA2CA9CES2CES1 | |
| SCHEMBL1589344 | 0.72 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 281 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4692166-A1 | METHOD FOR PRODUCING ACTIVATED POLYETHYLENE GLYCOL DERIVATIVE | NOF Corporation (JP) | 2026-02-11 | — | — | EP | claimed |
| WO-2024203596-A1 | METHOD FOR PRODUCING ACTIVATED POLYETHYLENE GLYCOL DERIVATIVE | 日油株式会社 | 2024-10-03 | — | — | WO | claimed |
| US-20210130546-A1 | METHODS FOR PREPARING POLYMERIC REAGENTS AND COMPOSITIONS OF POLYMERIC REAGENTS | NEKTAR THERAPEUTICS (US) | 2021-05-06 | — | — | US | claimed |
| EP-1922350-B1 | METHODS FOR PREPARING POLYMERIC REAGENTS | NEKTAR THERAPEUTICS (US) | 2015-01-07 | — | — | EP | claimed |
| US-20140088298-A9 | CONJUGATES COMPRISING HYDROXYALKYL STARCH AND A CYTOTOXIC AGENT AND PROCESS FOR THEIR PREPARATION | FRESENIUS KABI DEUTSCHLAND GMBH (DE) | 2014-03-27 | — | — | US | claimed |
| US-20140073778-A9 | CONJUGATES COMPRISING HYDROXYALKYL STARCH AND A CYTOTOXIC AGENT AND PROCESS FOR THEIR PREPARATION | FRESENIUS KABI DEUTSCHLAND GMBH (DE) | 2014-03-13 | — | — | US | claimed |
| US-20130211060-A1 | CONJUGATES COMPRISING HYDROXYALKYL STARCH AND A CYTOTOXIC AGENT AND PROCESS FOR THEIR PREPARATION | FRESENIUS KABI DEUTSCHLAND GMBH (DE) | 2013-08-15 | — | — | US | claimed |
| US-20130184454-A1 | CONJUGATES COMPRISING HYDROXYALKYL STARCH AND A CYTOTOXIC AGENT AND PROCESS FOR THEIR PREPARATION | FRESENIUS KABI DEUTSCHLAND GMBH (DE) | 2013-07-18 | — | — | US | claimed |
| US-8445734-B2 | Photolabile protective groups for improved processes to prepare oligonucleotide arrays | NIGU CHEMIE GMBH (DE) | 2013-05-21 | — | — | US | claimed |
| EP-2590680-A1 | CONJUGATES COMPRISING HYDROXYALKYL STARCH AND A CYTOTOXIC AGENT AND PROCESS FOR THEIR PREPARATION | Fresenius Kabi Deutschland GmbH (DE) | 2013-05-15 | — | — | EP | claimed |
| WO-2007016560-A2 | METHODS FOR PREPARING CARBONATE ESTERS OF POLY(ETYLENE GLYCOL) | NEKTAR THERAPEUTICS AL, CORPORATION (US) | 2007-02-08 | — | — | WO | claimed |
| US-20030144499-A1 | Photocleavable protecting groups and methods for their use | AFFYMETRIX, INC. (US) | 2003-07-31 | — | — | US | claimed |
| US-6147205-A | ARYLALKYLOXYCARBONYL GROUPS; FOR SOLID PHASE SYNTHESIS OF OLIGONUCLEOTIDES AND POLYPEPTIDES | AFFYMETRIX, INC. (US) | 2000-11-14 | — | — | US | claimed |
| WO-1998039348-A9 | PHOTOCLEAVABLE PROTECTING GROUPS AND METHODS FOR THEIR USE | — | 1999-02-18 | — | — | WO | claimed |
| WO-1998039348-A1 | PHOTOCLEAVABLE PROTECTING GROUPS AND METHODS FOR THEIR USE | AFFYMETRIX, INC. (US) | 1998-09-11 | — | — | WO | claimed |
| EP-0290313-B1 | PROCESS FOR OBTAINING ACTIVATED NITROSOCARBAMATES | SANOFI (FR) | 1992-03-04 | — | — | EP | claimed |
| US-4883903-A | FROM CHLOROETHYLAMINE, A HALOFORMATE; AND NITROSYL SULFURIC ACID | SANOFI (FR) | 1989-11-28 | — | — | US | claimed |
| EP-0038357-A4 | HYDROLYTIC ENZYME-ACTIVATIBLE PRO-DRUGS. | UNIV ILLINOIS (US) | 1982-03-22 | — | — | EP | claimed |
| EP-0038357-A1 | HYDROLYTIC ENZYME-ACTIVATIBLE PRO-DRUGS | University of Illinois Foundation (US) | 1981-10-28 | — | — | EP | claimed |
| WO-1981001145-A1 | HYDROLYTIC ENZYME-ACTIVATIBLE PRO-DRUGS | UNIV ILLINOIS (US) | 1981-04-30 | — | — | WO | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210130546-A1 | METHODS FOR PREPARING POLYMERIC REAGENTS AND COMPOSITIONS OF POLYMERIC REAGENTS | SI, PHYKPL, PHOSPHO1 | CA1 24/4885CA2 102/4885CA9 27/4885 |
| US-20140088298-A9 | CONJUGATES COMPRISING HYDROXYALKYL STARCH AND A CYTOTOXIC AGENT AND PROCESS FOR THEIR PREPARATION | HACL2, HASPIN, LIPA | CA1 4165/4885CA2 3932/4885CA9 1051/4885 |
| US-20130211060-A1 | CONJUGATES COMPRISING HYDROXYALKYL STARCH AND A CYTOTOXIC AGENT AND PROCESS FOR THEIR PREPARATION | HACL2, HASPIN, LIPA | CA1 4165/4885CA2 3932/4885CA9 1051/4885 |
| US-20030144499-A1 | Photocleavable protecting groups and methods for their use | RTCB, RRS1, GAR1 | CA1 3082/4885CA2 3886/4885CA9 4343/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.